Demonstration of efficacy in the treatment of dry eye disease with 0.18% sodium hyaluronate ophthalmic solution (vismed, rejena)

Am J Ophthalmol. 2010 Nov;150(5):757; author reply 757. doi: 10.1016/j.ajo.2010.08.005.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Administration, Topical
  • Coloring Agents
  • Cornea / drug effects
  • Cornea / pathology
  • Drug Approval
  • Dry Eye Syndromes / diagnosis
  • Dry Eye Syndromes / drug therapy*
  • Fluorophotometry
  • Humans
  • Hyaluronic Acid / administration & dosage*
  • Hyaluronic Acid / adverse effects
  • Lissamine Green Dyes
  • Ophthalmic Solutions / administration & dosage*
  • Ophthalmic Solutions / adverse effects
  • Pharmaceutical Vehicles / administration & dosage
  • Staining and Labeling / methods
  • Treatment Outcome
  • United States
  • United States Food and Drug Administration
  • Visual Acuity / physiology

Substances

  • Coloring Agents
  • Lissamine Green Dyes
  • Ophthalmic Solutions
  • Pharmaceutical Vehicles
  • Hyaluronic Acid